Cargando…
The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline
Dry eye syndrome is both a primary disease and a secondary result of many pathological states of the eye. The symptoms range from mild to severe itching, burning, irritation, eye fatigue, and even vision loss that can lead to disability. Dry eye affects approximately 60 million people worldwide; as...
Autores principales: | Vickers, Laura A., Gupta, Preeya K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675732/ https://www.ncbi.nlm.nih.gov/pubmed/26289997 http://dx.doi.org/10.1007/s40123-015-0038-y |
Ejemplares similares
-
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017) -
The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flares
por: Gupta, Preeya K., et al.
Publicado: (2021) -
Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
por: Venkateswaran, Nandini, et al.
Publicado: (2022) -
Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
por: Kim, Michelle J, et al.
Publicado: (2017) -
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment
por: Elbezanti, Weam Othman, et al.
Publicado: (2023)